NAGE Q1 2020 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M+42.8% YoY

Gross Profit

$8M57.9% margin

Operating Income

-$6M-41.1% margin

Net Income

-$6M-41.1% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$36M

Total Liabilities

$19M

Stockholders' Equity

$17M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+42.8%
Gross Profit	$8M	$5M	+56.8%
Operating Income	-$6M	-$8M	+29.6%
Net Income	-$6M	-$8M	+29.2%